HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Venture Life Acquires Helsinn Products As First-Half Sales Slide

Executive Summary

Venture Life has snapped up two self-care medical devices and a dietary supplement in the oncology support category from Switzerland's Helsinn. The company also reported a double-digit drop in first-half sales.

You may also be interested in...

EU Business News: Nestlé Acquires PronoKal, Bionorica Names International Head, Venture Life Gets New Partner

Round-up of the latest European consumer health industry news: Nestle Health Science has expanded its offering with the acquisition of weight management solution PronoKal; Germany's Bionorica has hired a new international business head; and the UK's Venture Life has appointed a Chinese distributor to grow sales of two of its key brands.

Venture Life Grabs BBI And Leading BV Brand Balance Activ

UK-based Venture Life has gained a foothold in the growing women's health category with the acquisition of BBI Healthcare and its leading OTC BV treatment Balance Activ.

Ireland Reviewing Codeine's OTC Status

Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts